These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33006904)

  • 1. Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study.
    Calhoun P; Price D; Beck RW
    Diabetes Technol Ther; 2021 Mar; 23(3):230-233. PubMed ID: 33006904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study.
    Valenzano M; Cibrario Bertolotti I; Valenzano A; Grassi G
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33514530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.
    Sandig D; Grimsmann J; Reinauer C; Melmer A; Zimny S; Müller-Korbsch M; Forestier N; Zeyfang A; Bramlage P; Danne T; Meissner T; Holl RW
    Diabetes Technol Ther; 2020 Aug; 22(8):602-612. PubMed ID: 32522039
    [No Abstract]   [Full Text] [Related]  

  • 7. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of use and improvement in glycemic indices after initiating continuous glucose monitoring in real world: Data from Saudi Arabia.
    Alyusuf EY; Alharthi S; Alguwaihes AM; Jammah AA; Alfadda AA; Al-Sofiani ME
    Diabetes Metab Syndr; 2022 Feb; 16(2):102416. PubMed ID: 35150962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
    Parkin CG; Graham C; Smolskis J
    J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.
    Grace T; Salyer J
    Diabetes Technol Ther; 2022 Jan; 24(1):26-31. PubMed ID: 34524013
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study.
    Danne T; Axel Schweitzer M; Keuthage W; Kipper S; Kretzschmar Y; Simon J; Wiedenmann T; Ziegler R
    Diabetes Technol Ther; 2021 Mar; 23(3):203-212. PubMed ID: 32924568
    [No Abstract]   [Full Text] [Related]  

  • 16. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections.
    McAuley SA; Vogrin S; Lee MH; Paldus B; Trawley S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Jenkins AJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Ward GM; Jones TW; O'Neal DN;
    Diabetes Technol Ther; 2021 Jun; 23(6):460-466. PubMed ID: 33351699
    [No Abstract]   [Full Text] [Related]  

  • 17. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion.
    Pinheiro SL; Bastos M; Barros L; Melo M; Paiva I
    Acta Diabetol; 2022 Apr; 59(4):509-515. PubMed ID: 34786633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
    Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
    Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.